377 related articles for article (PubMed ID: 8636444)
21. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors.
Mönig H; Ali IU; Oldfield EH; Schulte HM
Exp Clin Endocrinol; 1993; 101(1):36-8. PubMed ID: 8386673
[TBL] [Abstract][Full Text] [Related]
22. Ectopic secretion of peptides of the proopiomelanocortin family.
Schteingart DE
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):453-71. PubMed ID: 1657597
[TBL] [Abstract][Full Text] [Related]
23. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
[TBL] [Abstract][Full Text] [Related]
24. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
25. Proopiomelanocortin gene expression in normal and tumoral human lung.
Texier PL; de Keyzer Y; Lacave R; Vieau D; Lenne F; Rojas-Miranda A; Verley JM; Luton JP; Kahn A; Bertagna X
J Clin Endocrinol Metab; 1991 Aug; 73(2):414-20. PubMed ID: 1856267
[TBL] [Abstract][Full Text] [Related]
26. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors.
Vieau D; Seidah NG; Mbikay M; Chrétien M; Bertagna X
J Clin Endocrinol Metab; 1994 Nov; 79(5):1503-6. PubMed ID: 7962350
[TBL] [Abstract][Full Text] [Related]
27. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
[TBL] [Abstract][Full Text] [Related]
28. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
Dahia PL; Ahmed-Shuaib A; Jacobs RA; Chew SL; Honegger J; Fahlbusch R; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1996 May; 81(5):1768-71. PubMed ID: 8626831
[TBL] [Abstract][Full Text] [Related]
29. Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.
Arnaldi G; de Keyzer Y; Gasc JM; Clauser E; Bertagna X
Endocr Res; 1998; 24(3-4):807-16. PubMed ID: 9888581
[TBL] [Abstract][Full Text] [Related]
30. [Hormone production and abnormalities in gene expression in tumors].
Imura H; Nakai Y; Takahashi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):721-30. PubMed ID: 3008663
[TBL] [Abstract][Full Text] [Related]
31. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
[TBL] [Abstract][Full Text] [Related]
32. Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA.
Ma QY; Zhang XN; Jiang H; Wang ZQ; Zhang HJ; Xue LQ; Chen MD; Song HD
Mol Cell Endocrinol; 2011 Jul; 341(1-2):71-7. PubMed ID: 21664248
[TBL] [Abstract][Full Text] [Related]
33. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
34. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
35. RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome.
Messager M; Carrière C; Bertagna X; de Keyzer Y
Eur J Endocrinol; 2006 Jan; 154(1):159-66. PubMed ID: 16382005
[TBL] [Abstract][Full Text] [Related]
36. Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
Schteingart DE; Lloyd RV; Akil H; Chandler WF; Ibarra-Perez G; Rosen SG; Ogletree R
J Clin Endocrinol Metab; 1986 Sep; 63(3):770-5. PubMed ID: 3525603
[TBL] [Abstract][Full Text] [Related]
37. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
Arnaldi G; Gasc JM; de Keyzer Y; Raffin-Sanson ML; Perraudin V; Kuhn JM; Raux-Demay MC; Luton JP; Clauser E; Bertagna X
J Clin Endocrinol Metab; 1998 Jun; 83(6):2029-35. PubMed ID: 9626135
[TBL] [Abstract][Full Text] [Related]
38. Responses to corticotrophin-releasing hormone and dexamethasone in a large series of human adrenocorticotrophic hormone-secreting pituitary adenomas in vitro reveal manifold corticotroph tumoural phenotypes.
Pecori Giraldi F; Pagliardini L; Cassarino MF; Losa M; Lasio G; Cavagnini F
J Neuroendocrinol; 2011 Dec; 23(12):1214-21. PubMed ID: 21883533
[TBL] [Abstract][Full Text] [Related]
39. Proopiomelanocortin-derived peptides.
Bertagna X
Endocrinol Metab Clin North Am; 1994 Sep; 23(3):467-85. PubMed ID: 7805649
[TBL] [Abstract][Full Text] [Related]
40. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration.
Zhou Y; Franck J; Spangler R; Maggos CE; Ho A; Kreek MJ
Alcohol Clin Exp Res; 2000 Oct; 24(10):1575-82. PubMed ID: 11045867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
